{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:59:46Z","timestamp":1789261186097,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015131","name":"Foundation for Sarcoidosis Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015131","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bristol-Myers Squibb"},{"name":"Genenetech"},{"name":"Centocor"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1053\/j.ajkd.2010.08.019","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T05:12:46Z","timestamp":1288069966000},"page":"e17-e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Drug-Induced Granulomatous Interstitial Nephritis in a Patient With Ankylosing Spondylitis During Therapy With Adalimumab"],"prefix":"10.1053","volume":"56","author":[{"given":"Peter","family":"Korsten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Nagorsnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Niewold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann-Josef","family":"Gr\u00f6ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.ajkd.2010.08.019_bib1","first-page":"2129","article-title":"Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon?","volume":"34","author":"Sweiss","year":"2007","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.08.019_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.clindermatol.2007.03.012","article-title":"Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts","volume":"25","author":"Sweiss","year":"2007","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.08.019_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.ajkd.2010.08.019_bib4","unstructured":"Toussirot E, Pertuiset E. [TNFalpha blocking agents and sarcoidosis: an update.] [published online ahead of print May 24, 2010]. Rev Med Interne."},{"issue":"2 suppl 1","key":"10.1053\/j.ajkd.2010.08.019_bib5","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2010.08.019_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/MCP.0b013e3283056a61","article-title":"Diagnosis of sarcoidosis","volume":"14","author":"Costabel","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1053\/j.ajkd.2010.08.019_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00467-006-0318-9","article-title":"Drug-induced granulomatous interstitial nephritis in a pediatric patient","volume":"22","author":"Tong","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2010.08.019_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004836-198106000-00017","article-title":"Reversible sulfasalazine-induced granulomatous hepatitis","volume":"3","author":"Namias","year":"1981","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1053\/j.ajkd.2010.08.019_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1755-3768.2008.01302.x","article-title":"Tubulointerstitial nephritis and uveitis (TINU) syndrome: a case report and review of the literature","volume":"87","author":"Thomassen","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1053\/j.ajkd.2010.08.019_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Daien","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1053\/j.ajkd.2010.08.019_bib11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2007.078840","article-title":"Relapse of sarcoidosis upon treatment with etanercept","volume":"67","author":"Louie","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2010.08.019_bib12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2006.01949.x","article-title":"Granulomatous tattoo reaction in a patient treated with etanercept","volume":"21","author":"Bachmeyer","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1053\/j.ajkd.2010.08.019_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.22238","article-title":"Development of sarcoidosis during etanercept therapy","volume":"55","author":"Gonzalez-Lopez","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1053\/j.ajkd.2010.08.019_bib14","first-page":"645","article-title":"Sarcoid-related uveitis occurring during etanercept therapy","volume":"21","author":"Hashkes","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1053\/j.ajkd.2010.08.019_bib15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.21336","article-title":"Granulomatous lung disease occurring during etanercept treatment","volume":"53","author":"Phillips","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1053\/j.ajkd.2010.08.019_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1592\/phco.27.10.1446","article-title":"Pulmonary sarcoidosis associated with etanercept therapy","volume":"27","author":"Farah","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1053\/j.ajkd.2010.08.019_bib17","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s10067-007-0594-1","article-title":"Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients","volume":"26","author":"Verschueren","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1053\/j.ajkd.2010.08.019_bib18","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"issue":"3","key":"10.1053\/j.ajkd.2010.08.019_bib19","first-page":"471","article-title":"Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases","volume":"26","author":"Toussirot","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1053\/j.ajkd.2010.08.019_bib20","first-page":"349","article-title":"Granulomatous hepatitis associated with etanercept therapy","volume":"35","author":"Farah","year":"2008","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.08.019_bib21","first-page":"648","article-title":"Sarcoid-like granulomatous disease following etanercept treatment for RA","volume":"34","author":"Kudrin","year":"2007","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1053\/j.ajkd.2010.08.019_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2169\/internalmedicine.47.0602","article-title":"Development of sarcoidosis during etanercept therapy","volume":"47","author":"Ishiguro","year":"2008","journal-title":"Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2010.08.019_bib23","first-page":"99","article-title":"Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab","volume":"25","author":"Almodovar","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1053\/j.ajkd.2010.08.019_bib24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jbspin.2009.02.003","article-title":"Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient","volume":"76","author":"Josse","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1053\/j.ajkd.2010.08.019_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/rheumatology\/kep431","article-title":"Comment on: Sarcoid-like granulomatosis in patients treated with tumour necrosis factor blockers: 10 cases","volume":"49","author":"Massara","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1053\/j.ajkd.2010.08.019_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.22351","article-title":"Pulmonary sarcoidosis developing during infliximab therapy","volume":"55","author":"O'Shea","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1053\/j.ajkd.2010.08.019_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000275676","article-title":"Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases","volume":"220","author":"Dhaille","year":"2010","journal-title":"Dermatology"},{"issue":"11","key":"10.1053\/j.ajkd.2010.08.019_bib28","first-page":"2313","article-title":"Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab","volume":"34","author":"Sturfelt","year":"2007","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1053\/j.ajkd.2010.08.019_bib29","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1053\/j.ajkd.2010.08.019_bib30","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/art.23062","article-title":"Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept","volume":"56","author":"Mavragani","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1053\/j.ajkd.2010.08.019_bib31","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E","article-title":"Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy","volume":"43","author":"Ioannou","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1053\/j.ajkd.2010.08.019_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trsl.2009.08.012","article-title":"Genetic regulation of serum cytokines in systemic lupus erythematosus","volume":"155","author":"Kariuki","year":"2010","journal-title":"Transl Res"},{"issue":"1","key":"10.1053\/j.ajkd.2010.08.019_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.182.1.34","article-title":"Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo","volume":"182","author":"Kariuki","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1053\/j.ajkd.2010.08.019_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MD.0b013e31819de50f","article-title":"Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients","volume":"88","author":"Mahevas","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1053\/j.ajkd.2010.08.019_bib35","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s10067-006-0357-4","article-title":"Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab","volume":"26","author":"Ahmed","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1053\/j.ajkd.2010.08.019_bib36","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3899\/jrheum.090307","article-title":"Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge","volume":"36","author":"van der Stoep","year":"2009","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1053\/j.ajkd.2010.08.019_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610012990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610012990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:54:34Z","timestamp":1759456474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638610012990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0272638610012990"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.08.019","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Induced Granulomatous Interstitial Nephritis in a Patient With Ankylosing Spondylitis During Therapy With Adalimumab","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}